Lansforsakringar Fondforvaltning Ab (Publ) Incyte Corp Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $15.9 Billion
- Q1 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Incyte Corp stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 52,455 shares of INCY stock, worth $3.59 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
52,455
Previous 56,738
7.55%
Holding current value
$3.59 Million
Previous $3.92 Million
18.94%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.1 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.46 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.37 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.02 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$687 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...